Dipan Mehta of Elixir Equities notes a mixed earnings season with disappointments in major sectors like banking and software. However, urban consumption shows promising signs in QSR, retail, hospitality, healthcare, and travel. Mehta advises selectivity, favoring pharma companies with differentiated models, particularly CDMOs, while remaining cautious due to potential tariff impacts and base effects.
Smallcap Stars: 10 stocks rally up to 72% despite 11% Nifty crash in March. Do you own any?
Despite an 11% fall in the Nifty during March amid global tensions and rising crude prices, select smallcap stocks delivered strong gains of up to